{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:27:53Z","timestamp":1793309273238,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.metabol.2013.01.009","type":"journal-article","created":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T17:10:31Z","timestamp":1360084231000},"page":"970-975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Impaired glucose metabolism is a risk factor for increased thyroid volume and nodule prevalence in a mild-to-moderate iodine deficient area"],"prefix":"10.1016","volume":"62","author":[{"given":"Cuneyd","family":"Anil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysen","family":"Akkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semra","family":"Ayturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altug","family":"Kut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alptekin","family":"Gursoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2013.01.009_bb0005","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ecl.2007.04.009","article-title":"Thyroid nodules: clinical importance, assessment, and treatment","volume":"36","author":"Gharib","year":"2007","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.metabol.2013.01.009_bb0010","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1530\/EJE-09-0410","article-title":"Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area","volume":"161","author":"Ayturk","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2013.01.009_bb0015","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/thy.2007.0223","article-title":"Introducing the thyroid gland as another victim of the insulin resistance syndrome","volume":"18","author":"Rezzonico","year":"2008","journal-title":"Thyroid"},{"key":"10.1016\/j.metabol.2013.01.009_bb0020","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/02841850600806308","article-title":"Thyroid ultrasound in diabetic patients without overt thyroid disease","volume":"47","author":"Junik","year":"2006","journal-title":"Acta Radiol"},{"key":"10.1016\/j.metabol.2013.01.009_bb0025","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1590\/S0004-27302005000200009","article-title":"Thyroid disorders in diabetic patients","volume":"49","author":"Pimenta","year":"2005","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"2","key":"10.1016\/j.metabol.2013.01.009_bb0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1530\/EJE-12-0225","article-title":"Thyreotropin levels in diabetic patients on metformin treatment","volume":"167","author":"Cappelli","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.metabol.2013.01.009_bb0035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/met.2010.0026","article-title":"Metformin treatment for small benign thyroid nodules in patients with insulin resistance","volume":"9","author":"Rezz\u00f3nico","year":"2011","journal-title":"Metab Syndr Relat Disord"},{"issue":"2","key":"10.1016\/j.metabol.2013.01.009_bb0040","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/archinternmed.2011.677","article-title":"Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism","volume":"172","author":"Rhee","year":"2012","journal-title":"Arch Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.metabol.2013.01.009_bb0045","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.2337\/dc08-S055","article-title":"Diagnosis and classification of diabetes mellitus","volume":"1","author":"American Diabetes Association","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2013.01.009_bb0050","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/BF03343994","article-title":"Iodine status and goiter prevalence in Turkey before mandatory iodization","volume":"25","author":"Erdo\u011fan","year":"2002","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.metabol.2013.01.009_bb0055","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/thy.2008.0253","article-title":"More than a decade of iodine prophylaxis is needed to eradicate goiter among school age children in a moderately iodine-deficient region","volume":"19","author":"Erdo\u011fan","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.metabol.2013.01.009_bb0060","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/ajcn\/71.6.1421","article-title":"Effects of changes in body weight on carbohydrate metabolism, catecholamine excretion, and thyroid function","volume":"71","author":"Rosenbaum","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.metabol.2013.01.009_bb0065","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1530\/eje.0.1490257","article-title":"Circulating leptin and thyroid dysfunction","volume":"149","author":"Zimmermann-Belsing","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2013.01.009_bb0070","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1007\/s00125-006-0351-z","article-title":"Leptin and incident type 2 diabetes: risk or protection?","volume":"49","author":"Schmidt","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2013.01.009_bb0075","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1365-2265.2001.01243.x","article-title":"Effects of insulin and glucocorticoids on the leptin system are mediated through free leptin","volume":"54","author":"Lewandowski","year":"2001","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.metabol.2013.01.009_bb0080","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1677\/joe.0.1760007","article-title":"TSH stimulates leptin secretion by a direct effect on adipocytes","volume":"176","author":"Menendez","year":"2003","journal-title":"J Endocrinol"},{"key":"10.1016\/j.metabol.2013.01.009_bb0085","first-page":"673","article-title":"The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies","volume":"19","author":"Rapoport","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2013.01.009_bb0090","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1210\/edrv.22.5.0444","article-title":"Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models","volume":"22","author":"Kimura","year":"2001","journal-title":"Endocr Rev"},{"issue":"Suppl 1","key":"10.1016\/j.metabol.2013.01.009_bb0095","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1677\/erc.1.01280","article-title":"IGF1R signalling and its inhibition","volume":"13","author":"Riedemann","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.metabol.2013.01.009_bb0100","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1210\/jcem.81.11.8923818","article-title":"Insulin-like growth factor (IGF)-binding proteins in serum\u2013do they have additional roles besides modulating the endocrine IGF actions?","volume":"81","author":"Mohan","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2013.01.009_bb0105","first-page":"1310","article-title":"Insulin and insulin-like growth factor I regulate a thyroid-specific nuclear protein that binds to the thyroglobulin promoter","volume":"6","author":"Santisteban","year":"1992","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.metabol.2013.01.009_bb0110","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1210\/jc.2010-1255","article-title":"Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid","volume":"96","author":"Malaguarnera","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.metabol.2013.01.009_bb0115","doi-asserted-by":"crossref","first-page":"E2023","DOI":"10.1210\/jc.2010-1908","article-title":"Circulating adiponectin is inversely associated with risk of thyroid cancer: in vivo and in vitro studies","volume":"96","author":"Mitsiades","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2013.01.009_bb0120","doi-asserted-by":"crossref","first-page":"s858","DOI":"10.1093\/ajcn\/86.3.858S","article-title":"Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence","volume":"86","author":"Barb","year":"2007","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.metabol.2013.01.009_bb0125","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12020-007-9002-5","article-title":"Possible implications of leptin, adiponectin and ghrelin in the regulation of energy homeostasis by thyroid hormone","volume":"32","author":"Kokkinos","year":"2007","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.metabol.2013.01.009_bb0130","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.metabol.2009.06.032","article-title":"Circulating adiponectin concentrations were related to free thyroxine levels in thyroid cancer patients after thyroid hormone withdrawal","volume":"59","author":"Lin","year":"2010","journal-title":"Metabolism"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049513000139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049513000139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:01:38Z","timestamp":1758427298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049513000139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0026049513000139"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2013.01.009","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impaired glucose metabolism is a risk factor for increased thyroid volume and nodule prevalence in a mild-to-moderate iodine deficient area","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2013.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}